{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:11:38Z","timestamp":1791277898784,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.canlet.2008.03.036","type":"journal-article","created":{"date-parts":[[2008,5,8]],"date-time":"2008-05-08T09:41:21Z","timestamp":1210239681000},"page":"1-9","source":"Crossref","is-referenced-by-count":252,"title":["Genomic instability in myeloid malignancies: Increased reactive oxygen species (ROS), DNA double strand breaks (DSBs) and error-prone repair"],"prefix":"10.1016","volume":"270","author":[{"given":"Annahita","family":"Sallmyr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinshui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feyruz Virgilia","family":"Rassool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2008.03.036_bib1","first-page":"3230","article-title":"A mutator phenotype in cancer","volume":"61","author":"Loeb","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/CCO.0b013e3282f10e55","article-title":"Molecular characterization of acute myeloid leukemia and its impact on treatment","volume":"19","author":"Frankfurt","year":"2007","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canlet.2008.03.036_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.blre.2004.02.002","article-title":"Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders","volume":"19","author":"Kralovics","year":"2005","journal-title":"Blood Rev."},{"key":"10.1016\/j.canlet.2008.03.036_bib4","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/nrc2147","article-title":"Chronic myeloid leukaemia as a model of disease evolution in human cancer","volume":"7","author":"Melo","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2008.03.036_bib5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","article-title":"Genetic instabilities in human cancers","volume":"396","author":"Lengauer","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.03.036_bib6","series-title":"DNA Repair and Mutagenesis","author":"Friedberg","year":"1995"},{"key":"10.1016\/j.canlet.2008.03.036_bib7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-065X.2003.00060.x","article-title":"The role of DNA breaks in genomic instability and tumorigenesis","volume":"194","author":"Mills","year":"2003","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.canlet.2008.03.036_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1146\/annurev.me.43.020192.001001","article-title":"Chronic granulomatous disease","volume":"43","author":"Dinauer","year":"1992","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.canlet.2008.03.036_bib9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1042\/bj1340707","article-title":"The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen","volume":"134","author":"Boveris","year":"1973","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2008.03.036_bib10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/15230860260196218","article-title":"Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice","volume":"4","author":"Matsuzawa","year":"2002","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.canlet.2008.03.036_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.canlet.2008.03.036_bib12","doi-asserted-by":"crossref","first-page":"26467","DOI":"10.1074\/jbc.M500047200","article-title":"Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells. Novel evidence of the occurrence of NAD(P)H oxidase activity","volume":"280","author":"Piccoli","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2008.03.036_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0960-9822(02)00684-X","article-title":"Oxygen metabolism causes chromosome breaks and is associated with the neuronal apoptosis observed in DNA double-strand break repair mutants","volume":"12","author":"Karanjawala","year":"2002","journal-title":"Curr. Biol."},{"issue":"Pt 1","key":"10.1016\/j.canlet.2008.03.036_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/bj3130017","article-title":"Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer","volume":"313","author":"Wiseman","year":"1996","journal-title":"Biochem. J."},{"key":"10.1016\/j.canlet.2008.03.036_bib15","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4161\/cc.6.4.3886","article-title":"ATM and ATR: components of an integrated circuit","volume":"6","author":"Hurley","year":"2007","journal-title":"Cell Cycle"},{"key":"10.1016\/j.canlet.2008.03.036_bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/bss0730181","article-title":"The p53 response during DNA damage: impact of transcriptional cofactors","author":"Coutts","year":"2006","journal-title":"Biochem. Soc. Symp."},{"key":"10.1016\/j.canlet.2008.03.036_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.molcel.2004.10.029","article-title":"A pathway of double-strand break rejoining dependent upon ATM, Artemis, and proteins locating to gamma-H2AX foci","volume":"16","author":"Riballo","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.canlet.2008.03.036_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cell.2007.10.005","article-title":"A backup DNA repair pathway moves to the forefront","volume":"131","author":"Nussenzweig","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2008.03.036_bib19","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1158\/0008-5472.CAN-04-3055","article-title":"DNA ligase III as a candidate component of backup pathways of nonhomologous end joining","volume":"65","author":"Wang","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib20","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1093\/nar\/gkl840","article-title":"PARP-1 and Ku compete for repair of DNA double strand breaks by distinct NHEJ pathways","volume":"34","author":"Wang","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/0092-8674(94)90322-0","article-title":"Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation","volume":"77","author":"Golub","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2008.03.036_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/hon.761","article-title":"The V617F JAK2 mutation and the myeloproliferative disorders","volume":"23","author":"Percy","year":"2005","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.canlet.2008.03.036_bib23","doi-asserted-by":"crossref","first-page":"24273","DOI":"10.1074\/jbc.M002094200","article-title":"The BCR\/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells","volume":"275","author":"Sattler","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.canlet.2008.03.036_bib24","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1182\/blood-2004-05-1941","article-title":"BCR\/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double strand breaks","volume":"104","author":"Nowicki","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib25","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood-2004-09-3404","article-title":"Genetic rearrangements beget genomic instability","volume":"104","author":"Rassool","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib26","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1158\/0008-5472.CAN-06-4807","article-title":"Reactive oxygen species drive increased DNA damage and error-prone repair in a mouse model of myeloid leukaemia disease progression","volume":"67","author":"Rassool","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib27","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2007-05-092510","article-title":"Internal tandem duplication of FLT3 (FLT3\/ITD) induces increased ROS production, DNA damage and misrepair: implications for poor prognosis in AML","volume":"111","author":"Sallmyr","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib28","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2008.03.036_bib29","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00062752-200207000-00003","article-title":"Role of FLT3 in leukemia","volume":"9","author":"Gilliland","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.canlet.2008.03.036_bib30","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2008.03.036_bib31","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1182\/blood.V97.11.3589","article-title":"FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia","volume":"97","author":"Stirewalt","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib32","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1038\/sj.leu.2402674","article-title":"Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor","volume":"16","author":"Tse","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2008.03.036_bib33","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1182\/blood.V99.11.3885","article-title":"A FLT3-targeted tyrosine kinase inhibitor is cytotoxic to leukemia cells in vitro and in vivo","volume":"99","author":"Levis","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib34","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2006.06225.x","article-title":"Constitutively activated FLT3 phosphorylates BAD partially through Pim-1","author":"Kim","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.canlet.2008.03.036_bib35","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1182\/blood-2006-05-023804","article-title":"Prolonged exposure to FLT3 inhibitors leads to resistance via activation of parallel signaling pathways","volume":"109","author":"Piloto","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib36","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1002\/j.1460-2075.1996.tb00946.x","article-title":"DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites","volume":"15","author":"Vinkemeier","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2008.03.036_bib37","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1128\/MCB.23.16.5706-5715.2003","article-title":"Pathways of DNA double-strand break repair during the mammalian cell cycle","volume":"23","author":"Rothkamm","year":"2003","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2008.03.036_bib38","first-page":"913","article-title":"Interactive competition between homologous recombination and non-homologous end joining","volume":"1","author":"Allen","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib39","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2004-06-2459","article-title":"FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L)","volume":"105","author":"Bagrintseva","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib40","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1038\/sj.leu.2404439","article-title":"DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412","volume":"20","author":"Seedhouse","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2008.03.036_bib41","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/sj.leu.2401044","article-title":"RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias: a 10-year follow-up","volume":"12","author":"Padua","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.canlet.2008.03.036_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2008.03.036_bib43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1073\/pnas.0307203101","article-title":"Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder","volume":"101","author":"Braun","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.canlet.2008.03.036_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ccr.2004.07.011","article-title":"Antiapoptotic BCL-2 is required for maintenance of a model leukemia","volume":"6","author":"Letai","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2008.03.036_bib45","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1158\/0008-5472.CAN-07-0196","article-title":"BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia","volume":"67","author":"Omidvar","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1182\/asheducation-2001.1.87","article-title":"Chronic myelogenous leukemia","author":"Druker","year":"2001","journal-title":"Hematology (Am. Soc. Hematol. Educ. Prog.)"},{"key":"10.1016\/j.canlet.2008.03.036_bib47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0950-3536(97)80004-2","article-title":"Signal transduction pathways involved in BCR\u2013ABL transformation","volume":"10","author":"Sawyers","year":"1997","journal-title":"Baillieres Clin. Haematol."},{"key":"10.1016\/j.canlet.2008.03.036_bib48","doi-asserted-by":"crossref","first-page":"8591","DOI":"10.1038\/sj.onc.1206087","article-title":"BCR\/ABL regulates response to DNA damage: the role in resistance to genotoxic treatment and in genomic instability","volume":"21","author":"Skorski","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.03.036_bib49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cbpc.2006.06.010","article-title":"Comparative study of DNA damage, cell cycle and apoptosis in human K562 and CCRF-CEM leukemia cells: role of BCR\/ABL in therapeutic resistance","volume":"144","author":"Pytel","year":"2006","journal-title":"Comp. Biochem. Physiol. C Toxicol. Pharmacol."},{"key":"10.1016\/j.canlet.2008.03.036_bib50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/cbir.2002.0865","article-title":"Does the bcr\/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells?","volume":"26","author":"Majsterek","year":"2002","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.canlet.2008.03.036_bib51","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1128\/MCB.22.12.4189-4201.2002","article-title":"Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)\/M phase, and protection from apoptosis","volume":"22","author":"Slupianek","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.canlet.2008.03.036_bib52","first-page":"1798","article-title":"Increased error-prone NHEJ activity in myeloid leukemias is associated with DNA damage at sites that recruit key nonhomologous end-joining proteins","volume":"63","author":"Brady","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib53","first-page":"2791","article-title":"Myeloid leukemias have increased activity of the nonhomologous end-joining pathway and concomitant DNA misrepair that is dependent on the Ku70\/86 heterodimer","volume":"62","author":"Gaymes","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib54","article-title":"Effect of double-strand break DNA sequence on the PARP-1 NHEJ pathway","author":"Audebert","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.canlet.2008.03.036_bib55","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/nature06020","article-title":"IgH class switching and translocations use a robust non-classical end-joining pathway","volume":"449","author":"Yan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.03.036_bib56","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature06168","article-title":"Rag mutations reveal robust alternative end joining","volume":"449","author":"Corneo","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2008.03.036_bib57","doi-asserted-by":"crossref","first-page":"7780","DOI":"10.1038\/sj.onc.1210875","article-title":"V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining","volume":"26","author":"Soulas-Sprauel","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2008.03.036_bib58","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1182\/blood.V97.7.2084","article-title":"BCR\u2013ABL down-regulates the DNA repair protein DNA-PKcs","volume":"97","author":"Deutsch","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib59","doi-asserted-by":"crossref","first-page":"308a","DOI":"10.1182\/blood.V110.11.1016.1016","article-title":"Up-regulation of WRN and DNA ligase III\u03b1 in chronic myeloid leukemia: consequences for the repair of DNA double strand breaks","volume":"110","author":"Sallmyr","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.canlet.2008.03.036_bib60","doi-asserted-by":"crossref","first-page":"8449","DOI":"10.1158\/1078-0432.CCR-05-1224","article-title":"The novel poly(ADP-Ribose) polymerase inhibitor, AG14361, sensitizes cells to topoisomerase I poisons by increasing the persistence of DNA strand breaks","volume":"11","author":"Smith","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2008.03.036_bib61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","article-title":"FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress","volume":"128","author":"Tothova","year":"2007","journal-title":"Cell"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508002462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383508002462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T07:13:15Z","timestamp":1588662795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383508002462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0304383508002462"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2008.03.036","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}